Origin of Waldenstrom's macroglobulinaemia
Ram
on García-Sanz
a, *
, Cristina Jim
enez
a
, Noemí Puig
a
,
Bruno Paiva
b
, Norma C. Guti
errez
a
, Paula Rodríguez-Otero
b
,
Julia Almeida
c
, Jesús San Miguel
b
, Alberto Orf
~
ao
c
,
Marcos Gonz
alez
a
, Martín P
erez-Andr
es
c
a
Servicio de Hematología, Hospital Universitario de Salamanca, Instituto de Investigaci on Biom edica de
Salamanca, Centro de Investigaci on del C ancer de Salamanca, Salamanca, Spain
b
Clínica Universidad de Navarra, Centro de Investigaci on M edica Aplicada, Instituto De Investigaci on
Sanitaria De Navarra, Pamplona, Spain
c
Servicio General de Citometría de la Universidad de Salamanca, Salamanca, Spain
Keywords:
Waldenstrom's macroglobulinaemia
Flow cytometry
Immunophenotyping
B lymphocytes
abstract
Waldenstrom's macroglobulinaemia (WM) is an MYD88
L265P
-
mutated lymphoplasmacytic lymphoma that invades bone marrow
and secretes monoclonal immunoglobulin M (IgM). WM cells are
usually unable to undergo class switch recombination, and have
mutated IGHV, with a typical immunophenotype CD19
þ
/CD22
lowþ
/
CD23
e
/CD25
þ
/CD27
þ
/CD45
þ
/CD38
lowþ
/SmIgM
þ
(negative for CD5,
CD10, CD11c, CD103). This immunophenotype matches memory
B cells (smIgM
e/þ
/CD10
e
/CD19
þ
/CD20
þ
/CD27
þ
/CD38
lowþ
/CD45
þ
),
representing 30% of B cells in the blood. Fifty percent of them have
not undergone class switch recombination and are IgM
þ
. These
cells have suffered somatic hypermutation as WM cells. Genetic
abnormalities do not abrogate the capacity to progress to plasma
cells that usually belong to the clonal WM compartment, with a
normal immunophenotype and functional characteristics. How-
ever, some WM cells are CD27
, MYD88
WT
, without somatic
hypermutation, or with class switch recombination capable of
reactivation. Thus, most data support a B-memory-cell origin for
WM, but a small fraction of cases may have a different origin.
© 2016 Elsevier Ltd. All rights reserved.
* Corresponding author. Servicio de Hematología, Hospital Universitario de Salamanca, Pº San Vicente 58-182, 37007 Sala-
manca, Spain. Fax: þ34 923 29 46 24.
E-mail address: rgarcias@usal.es (R. García-Sanz).
Contents lists available at ScienceDirect
Best Practice & Research Clinical
Haematology
journal homepage: www.elsevier.com/locate/beha
http://dx.doi.org/10.1016/j.beha.2016.08.024
1521-6926/© 2016 Elsevier Ltd. All rights reserved.
Best Practice & Research Clinical Haematology 29 (2016) 136e147
Downloaded from ClinicalKey.com at University of Pittsburgh January 31, 2017.
For personal use only. No other uses without permission. Copyright ©2017. Elsevier Inc. All rights reserved.